Ipamorelin drives potent and dose-dependent GH release from pituitary somatotroph cells with selectivity equivalent to the most refined second-generation GH secretagogues , making it the primary research tool for studying GHS-R1a-mediated somatotroph biology where GH-specific downstream effects must be studied free from prolactin and cortisol co-secretion confounds
These are all manifestations of the havoc wreaked by free radicals
Any such prior disclosure normally is considered unethical and unprofessional in the scientific research arena.** So, what is so special about the EPIC Trial that this seemingly unethical, unprofessional, and unheard of press release has been issued
It gives your body time to reset natural peptide production
Ultimately, when making treatment decisions, clinicians should consider the individual needs of each patient
It validates years of advocacy by clinical organizations arguing that compounding restrictions should be proportional to actual patient risk not applied uniformly across categories